9KBO | pdb_00009kbo

Crystal structure of human Shiftless (SFL) containing phosphorylation sites Ser249, Thr250, Thr253 and Ser256


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.286 (Depositor), 0.285 (DCC) 
  • R-Value Work: 
    0.222 (Depositor), 0.222 (DCC) 
  • R-Value Observed: 
    0.225 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9KBO

This is version 1.1 of the entry. See complete history

Literature

Phosphorylation of shiftless is important for inhibiting the programmed -1 ribosomal frameshift.

Zhang, Y.Li, Z.Chong, H.Hou, P.Hao, W.Li, M.Liu, Z.Jia, W.Qin, B.He, Y.Cui, S.

(2025) Sci Adv 11: eadw7471-eadw7471

  • DOI: https://doi.org/10.1126/sciadv.adw7471
  • Primary Citation Related Structures: 
    9KBO

  • PubMed Abstract: 

    Shiftless (SFL) is a broad-spectrum inhibitor of programmed -1 ribosomal frameshift (-1 PRF) and exhibits various antiviral activities. Here, we characterized human SFL structurally and biochemically. The 2.0-angstrom resolution crystal structure of SFL reveals a boat-like module comprising an N-terminal helical bundle and three zinc fingers at the C terminus. A hyperphosphorylation loop (HPL) buried between the helical bundle and the zinc finger 1 harbors four phosphorylated residues (p-S249, p-T250 p-T253, and p-S256), which are important to protein folding. SFL forms monomers in solution and binds the HIV-1 -1 PRF sequence with nanomolar affinity ( K D  = 5.7 nanomolar). Disruption of HPL phosphorylation decreased the RNA binding affinity and undermined the SFL-mediated -1 PRF inhibition of various viruses. Proximity-dependent biotinylation identified three cellular Ser/Thr kinases-EEF2K, NEK9, and PBK-that phosphorylate SFL in cells. These findings shed light on the mechanisms underlying -1 PRF regulation by SFL and provide insights into the role of SFL in virus inhibition.


  • Organizational Affiliation
    • NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Macromolecule Content 

  • Total Structure Weight: 134.37 kDa 
  • Atom Count: 8,732 
  • Modeled Residue Count: 1,019 
  • Deposited Residue Count: 1,164 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Shiftless antiviral inhibitor of ribosomal frameshifting protein
A, B, C, D
291Homo sapiensMutation(s): 0 
Gene Names: SHFLC19orf66FLJ11286IRAVRYDENSFL
UniProt & NIH Common Fund Data Resources
Find proteins for Q9NUL5 (Homo sapiens)
Explore Q9NUL5 
Go to UniProtKB:  Q9NUL5
PHAROS:  Q9NUL5
GTEx:  ENSG00000130813 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9NUL5
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
ZN
(Subject of Investigation/LOI)

Query on ZN



Download:Ideal Coordinates CCD File
E [auth A]
F [auth A]
G [auth A]
H [auth B]
I [auth B]
E [auth A],
F [auth A],
G [auth A],
H [auth B],
I [auth B],
J [auth B],
K [auth C],
L [auth C],
M [auth C],
N [auth D],
O [auth D]
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
Modified Residues  2 Unique
IDChains TypeFormula2D DiagramParent
SEP
Query on SEP
A, B, C, D
L-PEPTIDE LINKINGC3 H8 N O6 PSER
TPO
Query on TPO
A, B, C, D
L-PEPTIDE LINKINGC4 H10 N O6 PTHR

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.286 (Depositor), 0.285 (DCC) 
  • R-Value Work:  0.222 (Depositor), 0.222 (DCC) 
  • R-Value Observed: 0.225 (Depositor) 
Space Group: P 21 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 211.719α = 90
b = 89.411β = 90
c = 82.265γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
PDB_EXTRACTdata extraction
XDSdata reduction
PHENIXphasing
STARANISOdata scaling

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2025-11-19
    Type: Initial release
  • Version 1.1: 2025-12-31
    Changes: Database references, Structure summary